2013-09-17 10:31:51 - ResearchInChina, the vertical portal for Chinese business intelligence, announces the release of a new report – China Orthopedic Instrument Industry Report, 2013-2015. For more information, please contact us at firstname.lastname@example.org or at 86-10-82600828.
For details of this report please visit researchinchina.com/Htmls/Report/2013/6744.html
Benefiting from aging of population, consumption upgrade and policy support, China's orthopedic instrument industry has seen rapid development over the years, with total market size rising from 3.28 billion yuan in 2006 to 9.85 billion yuan in 2012.
Trauma products, spine products and joint products constitute the three major market segments of Chinese orthopedic instrument industry. In 2012, the three principal products accounted for an aggregate market share of about 82.2%, of which, trauma products showed the highest, approximately 35.5%, with market size up 18.24% YoY; spine and joint products ranked second (up 12.6% YoY) and third (up 12.4% YoY), respectively.
In recent years, along with the increasing investment of foreign-funded enterprises
in China, the trend of foreign monopoly has been more evident. After the acquisition of Synthes in 2012, Johnson & Johnson has turned into the largest company in China's orthopedic instrument market, with market share of both trauma and spine products occupying the first place.
In November 2012, Medtronic purchased KangHui Medical for $816 million, thus making an important step in Chinese orthopedic instrument market localization. Compared with Medtronic's high-end positioning, affordable KangHui products can help Medtronic expand low- and medium-end markets in emerging countries and regions (including China). In 2012, Medtronic (including KangHui Medical) occupied 15.9% of China's spine market.
Stryker is a world-renowned orthopedic instrument enterprise, and its joint products account for about 20% of global market share. In January 2013, Stryker acquired Trauson Holdings for $764 million, and in virtue of the latter’s R&D and manufacturing capacity and distribution network advantages further expanded its market share in China, expected to occupy 8%-10% of China's orthopedic market in 2013.
Relying on powerful R&D strength and mature distribution network, Weigao has already become the largest local supplier of orthopedic devices in China. In 2012, its orthopedic device business achieved revenue of 223 million yuan, and trauma equipment products occupied market share of 5.1% or so.
In future, the Chinese orthopedic instrument market will encounter more fierce competition, in which small companies due to low R&D level, insufficient production capacity and non-standard quality control tend to be gradually eliminated, and the market will be further concentrated in industry magnates with superb financial and technical strength.
China Orthopedic Instrument Industry Report, 2013-2015 of ResearchInChina mainly covers the followings:
Overview, market structure and development prospect, etc. of global orthopedic instrument industry;
Market structure, competition pattern, barriers to entry, import & export, etc. of China orthopedic instrument industry;
Development environment (including policy environment, development prospects as well as development of upstream and downstream industries) for China orthopedic instrument industry;
Operating conditions, etc. of 12 orthopedic instrument companies (including Johnson & Johnson, Medtronic, Stryker, Weigao, Shanghai Kinetic, Beijing AKEC Medical, United Orthopedic Corporation, etc.) in China.
1. Overview of Orthopedic Instrument Industry
1.3 Industry Chain
2. Development of Global Orthopedic Instrument Industry
2.2 Development Prospect
3. Development of China Orthopedic Instrument Industry
3.2 Market Structure
3.3 Import & Export
3.4 Competition Pattern
3.5 Barriers to Entry
3.5.2 Market Access
3.5.3 Sales Channel
3.6 Sales Model
4. Development Environment for China Orthopedic Instrument Industry
4.1 Policy Environment
4.1.1 Regulatory Policy
4.1.2 Industry Policy
4.2 Upstream and Downstream Industries
4.3 Development Prospects
5. Key Companies in China
5.1 Johnson & Johnson
5.1.3 Orthopedic Instrument Business
5.1.4 Business in China
5.2.3 Orthopedic Instrument Business
5.2.4 Revenue Structure
5.2.5 Business in China
5.3.3 Revenue Structure
5.3.4 Business in China
5.4.3 Revenue Structure
5.4.4 Orthopedic Instrument Business
5.4.5 Gross Margin
5.4.6 R&D and Investment
5.4.8 Forecast and Outlook
5.5 Shanghai Kinetic Medical Co., Ltd. (KMC)
5.5.3 Revenue Structure
5.5.4 Orthopedic Instrument Business
5.5.5 Gross Margin
5.5.6 R&D and Investment
5.5.7 Clients and Suppliers
5.5.8 Forecast and Outlook
5.6 United Orthopedic Corporation
5.6.3 Revenue Structure
5.6.4 Orthopedic Instrument Business
5.6.5 Gross Margin
5.6.6 R&D and Investment
5.6.7 Clients and Suppliers
5.7 Beijing AKEC Medical Co. Ltd. (AKEC)
5.7.3 Revenue Structure
5.7.4 Gross Margin
5.7.5 R&D and Investment
5.7.6 Clients and Suppliers
5.8 Suzhou Xinrong Best Medical Instrument Co,. Ltd.
5.9 Tianjin Walkman Biomaterial Co., Ltd.
5.10 Beijing Montagne Medical Device Co., Ltd.
5.11 Beijing Lidakang Science and Technology Co., Ltd.
5.12 Renli Orthopedics Medical Instrument Limited Company